Log In
BCIQ
Print this Print this
 

YS110 (formerly YSCMA)

  Manage Alerts
Collapse Summary General Information
Company Kissei Pharmaceutical Co. Ltd.
DescriptionHumanized mAb targeting CD26
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today